Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
about
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammationFulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin.Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.Treatment Strategies for Recurrent Clostridium difficile Infection.Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation.Impact of Clostridium difficile on inflammatory bowel disease.Treatment of refractory and recurrent Clostridium difficile infection.Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile.Demonstration of conjugative transposon (Tn5397)-mediated horizontal gene transfer between Clostridium difficile and Enterococcus faecalis.The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.Increase in use of vancomycin for Clostridium difficile infection in US hospitals.A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile.
P2860
Q33398747-2645CB16-8C8E-486E-A2D0-7291B9F7F20AQ35044119-F5229D12-F2D8-4730-A63C-0CEA5737C4C9Q36367042-E75B0113-28A2-4F49-90BF-DA38E3877385Q36571896-86E96FE3-A2EA-4EEC-B023-FB8B048BF4A4Q36646782-A59D4E46-E247-4413-A7DE-84363D4F3726Q36680914-1A1F21CF-E0F8-4D92-A34A-D91D96DEFCA6Q36999988-34C1C05D-CEBD-4B18-AAFA-421B6679E725Q37402287-1CB724F4-4AD1-4699-97AD-FD25FE6D0DD2Q37465285-241AA817-18E8-4B62-ABBA-542BBD6D3438Q37798821-C6C8DDA3-7D50-45E6-B663-80327FDBFEE9Q37866629-8A945949-4394-4B0B-9F53-D26F1C598E77Q38679129-B2D3AEBD-C2C1-42B8-AD34-A02ABCB2FB4CQ39388122-E106A512-2817-4D23-B2A4-16FA74E517EEQ41175414-77296A0E-E239-4361-8810-E264A012DF32Q41771638-F00CF569-08E0-4FD2-91A1-31408DD678FBQ42251311-1CB7B30F-5D76-4842-BD3B-FF865285E2A1Q42274443-34420F67-8CB1-4264-802F-39E8917D9200Q43002296-4EAA965A-29D0-4E44-86AE-AA4A6C521A47Q43886607-601C0856-308E-417A-9B67-8E06D0203A72Q44982093-BFB793F4-D641-48E6-8B1D-DFEDEAF06D98Q46111002-C95742ED-12B7-4C1C-AB6A-39E3016BA4DCQ52576450-90027529-176E-4EE1-8958-F89BD10AD2E3
P2860
Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Vancomycin for the treatment o ...... expensive bullet really magic?
@en
type
label
Vancomycin for the treatment o ...... expensive bullet really magic?
@en
prefLabel
Vancomycin for the treatment o ...... expensive bullet really magic?
@en
P356
P1476
Vancomycin for the treatment o ...... expensive bullet really magic?
@en
P2093
Jacques Pepin
P304
P356
10.1086/587656
P407
P577
2008-05-01T00:00:00Z